New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
15:26 EDTMYL
theflyonthewall.com: Mylan receives FDA approval for generic version of Prevacid
Mylan announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. FDA for its Abbreviated New Drug Application for Lansoprazole Delayed-release Capsules, 15 mg and 30 mg. This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand. Lansoprazole DR Capsules are the generic version of Tap Pharmaceuticals' proton pump inhibitor Prevacid DR Capsules. The brand product had U.S. sales of approximately $3B for the 12 months ending June 30, according to IMS Health. Currently, Mylan has 125 ANDAs pending FDA approval representing $84.1B in annual brand sales, according to IMS Health. Thirty-seven of these pending ANDAs are potential first-to-file opportunities, representing $19.2B in annual brand sales, for the 12 months ending June 30, according to IMS Health. :theflyonthewall.com



News For MYL From The Last 14 Days
Check below for free stories on MYL the last two weeks.
There are 6 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
18:41 EDTMYL
theflyonthewall.com: Mylan awarded NABP-VAWD accreditation for distribution facility
Mylan announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors accreditation from the National Association of Boards of Pharmacy. The NABP established the VAWD program in 2004 to help protect the public from the threat of counterfeit drugs affecting the U.S. drug supply. According to IMS Health data, one out of every 12 prescriptions dispensed in the U.S. - branded or generic - is a Mylan product, and most of these are distributed by the company's Greensboro facility. :theflyonthewall.com

February 5, 2010
08:27 EDTMYL
theflyonthewall.com: Mylan's vertical move into generic drugs pays off, IBD reports

Subscribe for More Information :theflyonthewall.com

February 4, 2010
11:40 EDTMYL
theflyonthewall.com: Mylan confirms lawsuit by Pfizer over generic Caduet

Subscribe for More Information :theflyonthewall.com

February 3, 2010
09:00 EDTMYL
theflyonthewall.com: On The Fly: Analysts Initiation Summary

Subscribe for More Information :theflyonthewall.com

February 2, 2010
16:30 EDTMYL
theflyonthewall.com: Mylan initiated with an Outperform at Oppenheimer

Subscribe for More Information :theflyonthewall.com

January 29, 2010
10:39 EDTMYL
theflyonthewall.com: Mylan receives approval for generic version of GoLytely(R)

Subscribe for More Information :theflyonthewall.com